FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
 OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Furlow Brenda S.		 2. Issuer Name and Ticker or Trading Symbol

BIO-TECHNE Corp [ TECH ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
SVP - General Counsel
(Last)          (First)          (Middle)

614 MCKINLEY PLACE NE		 3. Date of Earliest Transaction (MM/DD/YYYY)

8/8/2022
(Street)

MINNEAPOLIS, MN 55413
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
 6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 8/8/2022  M  563 A$177.32 6523 D  
Common Stock         1330 I By Trust #1 
Common Stock         1330 I By Trust #2 

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)		2. Conversion or Exercise Price of Derivative Security3. Trans. Date3A. Deemed Execution Date, if any4. Trans. Code
(Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)		8. Price of Derivative Security
(Instr. 5)		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Options (Right to Buy) $125.0500            (2)8/9/2024 Common Stock 9503  9503 D  
Stock Options (Right to Buy) $177.32 8/8/2022  M     563   (2)8/8/2025 Common Stock 563 $0 16562 D  
Stock Options (Right to Buy) $190.4100            (3)8/7/2026 Common Stock 9968  9968 D  
Stock Options (Right to Buy) $190.4100            (4)8/7/2026 Common Stock 13290  13290 D  
Restricted Stock Units  (1)           (5) (5)Common Stock 1679  1679 D  
Stock Options (Right to Buy) $267.8700            (5)8/5/2027 Common Stock 7492  7492 D  
Stock Options (Right to Buy) $267.8700            (6)8/5/2027 Common Stock 9990  9990 D  
Stock Options (Right to Buy) $267.8700            (7)8/5/2027 Common Stock 8325  8325 D  
Stock Options (Right to Buy) $267.8700            (8)8/5/2027 Common Stock 8325  8325 D  
Stock Options (Right to Buy) $372.4400           8/31/2022 3/1/2028 Common Stock 10997  10997 D  
Restricted Stock Units  (1)           (9) (9)Common Stock 1167  1167 D  
Stock Options (Right to Buy) $481.8200            (9)8/6/2028 Common Stock 4560  4560 D  
Stock Options (Right to Buy) $481.8200            (10)8/6/2028 Common Stock 6080  6080 D  
Explanation of Responses:
(1) Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
(2) Fully exercisable.
(3) On 8/7/22, the Board of Directors certified vesting of 1,969 performance RSUs.
(4) Options to purchase 3,323 shares vest on each of 8/7/2020 and 8/7/2021 and options to purchase 3,322 shares vest on each of 8/7/2022 and 8/7/2023.
(5) Vests in full or in part on 8/5/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
(6) Options to purchase 2,497 shares vest on each of 8/5/2021 and 8/5/2022 and options to purchase 2,498 shares vest on each of 8/5/2023 and 8/5/2024.
(7) Vests in full on the date performance of certain product revenue goals during the period of fiscal 2021-2023 is certified by the Administrator, in no event earlier than 8/5/2021.
(8) Options to purchase 2,775 shares vest on each of 8/5/2021, 8/5/2022 and 8/5/2023.
(9) Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
(10) Options to purchase 1,520 shares vest on each of 8/6/2022, 8/6/2023, 8/6/2024 and 8/6/2025.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Furlow Brenda S.
614 MCKINLEY PLACE NE
MINNEAPOLIS, MN 55413

SVP - General Counsel
Signatures
/s/ Andrew Nick as Attorney-in-Fact for Brenda S. Furlow pursuant to Power of Attorney previously filed.8/10/2022
**Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Bio Techne (NASDAQ:TECH)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Bio Techne Charts.
Bio Techne (NASDAQ:TECH)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Bio Techne Charts.